Ameriprise
HOLX

Ameriprise’s Hologic HOLX Stock Holding History

Ameriprise’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-618,084
Closed -$46.7M – 4165
2026
Q1 		$46.7M Sell
618,084
-198,206
-24% -$14.9M 0.01% 905
2025
Q4 		$60.8M Buy
816,290
+367
+0% +$26.8K 0.01% 775
2025
Q3 		$55.1M Sell
815,923
-1,125,831
-58% -$74.7M 0.01% 830
2025
Q2 		$127M Sell
1,941,754
-1,570,840
-45% -$94.2M 0.03% 474
2025
Q1 		$217M Buy
3,512,594
+29,133
+0.8% +$1.93M 0.06% 311
2024
Q4 		$251M Sell
3,483,461
-121,463
-3% -$9.49M 0.06% 286
2024
Q3 		$294M Buy
3,604,924
+113,347
+3% +$9.07M 0.08% 271
2024
Q2 		$259M Sell
3,491,577
-14,477
-0.4% -$1.09M 0.07% 281
2024
Q1 		$273M Sell
3,506,054
-37,420
-1% -$2.78M 0.08% 271
2023
Q4 		$253M Buy
3,543,474
+398,330
+13% +$27.7M 0.08% 272
2023
Q3 		$218M Sell
3,145,144
-376,999
-11% -$28.5M 0.07% 282
2023
Q2 		$285M Buy
3,522,143
+14,476
+0.4% +$1.18M 0.09% 234
2023
Q1 		$283M Buy
3,507,667
+1,065,767
+44% +$85.8M 0.09% 231
2022
Q4 		$183M Buy
2,441,900
+389,428
+19% +$27.7M 0.06% 313
2022
Q3 		$133M Buy
2,052,472
+732,703
+56% +$50.8M 0.05% 384
2022
Q2 		$91.3M Buy
1,319,769
+416,518
+46% +$30.9M 0.03% 511
2022
Q1 		$68.7M Buy
903,251
+120,151
+15% +$8.64M 0.02% 668
2021
Q4 		$59.5M Buy
783,100
+384,139
+96% +$28.2M 0.02% 765
2021
Q3 		$29.4M Sell
398,961
-164,920
-29% -$12.4M 0.01% 1013
2021
Q2 		$37.6M Sell
563,881
-333,788
-37% -$22.3M 0.01% 930
2021
Q1 		$66.8M Sell
897,669
-949,847
-51% -$72.1M 0.02% 641
2020
Q4 		$135M Buy
1,847,516
+760,839
+70% +$53.7M 0.05% 391
2020
Q3 		$72.5M Buy
1,086,677
+42,828
+4% +$2.71M 0.03% 511
2020
Q2 		$59.5M Sell
1,043,849
-25,650
-2% -$1.26M 0.03% 553
2020
Q1 		$37.5M Sell
1,069,499
-372,801
-26% -$17.7M 0.02% 651
2019
Q4 		$75.3M Buy
1,442,300
+187,979
+15% +$9.36M 0.03% 526
2019
Q3 		$63.3M Buy
1,254,321
+655,766
+110% +$32.3M 0.03% 556
2019
Q2 		$28.7M Buy
598,555
+118,475
+25% +$5.48M 0.01% 935
2019
Q1 		$23.2M Sell
480,080
-118,813
-20% -$5.36M 0.01% 1033
2018
Q4 		$24.6M Sell
598,893
-213,264
-26% -$8.75M 0.01% 937
2018
Q3 		$33.3M Sell
812,157
-103,141
-11% -$4.17M 0.01% 958
2018
Q2 		$36.4M Sell
915,298
-866
-0.1% -$33.3K 0.02% 820
2018
Q1 		$34.2M Buy
916,164
+92,080
+11% +$3.72M 0.02% 837
2017
Q4 		$35.2M Buy
824,084
+11,625
+1% +$464K 0.02% 727
2017
Q3 		$29.8M Sell
812,459
-572,387
-41% -$23.1M 0.01% 803
2017
Q2 		$62.8M Sell
1,384,846
-1,181,569
-46% -$52.2M 0.03% 484
2017
Q1 		$109M Sell
2,566,415
-883,716
-26% -$36M 0.06% 326
2016
Q4 		$138M Sell
3,450,131
-243,200
-7% -$9.38M 0.08% 271
2016
Q3 		$143M Buy
3,693,331
+3,021,732
+450% +$114M 0.08% 248
2016
Q2 		$23.2M Buy
671,599
+443,755
+195% +$15.4M 0.01% 825
2016
Q1 		$7.86M Sell
227,844
-526,572
-70% -$18.4M ﹤0.01% 1622
2015
Q4 		$29.2M Sell
754,416
-21,029
-3% -$818K 0.02% 713
2015
Q3 		$30.3M Buy
775,445
+91,782
+13% +$3.64M 0.02% 687
2015
Q2 		$26M Buy
683,663
+28,530
+4% +$999K 0.01% 834
2015
Q1 		$21.6M Buy
655,133
+37,195
+6% +$1.14M 0.01% 952
2014
Q4 		$16.5M Buy
617,938
+2,661
+0.4% +$68.7K 0.01% 1092
2014
Q3 		$15M Sell
615,277
-77,281
-11% -$1.95M 0.01% 1146
2014
Q2 		$17.6M Sell
692,558
-17,301
-2% -$404K 0.01% 1111
2014
Q1 		$15.3M Buy
709,859
+50,719
+8% +$1.09M 0.01% 1193
2013
Q4 		$14.7M Sell
659,140
-563,399
-46% -$12.4M 0.01% 1217
2013
Q3 		$25.2M Buy
1,222,539
+93,906
+8% +$2M 0.02% 872
2013
Q2 		$21.8M Buy
+1,128,633
New +$23.6M 0.02% 925

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameriprise's HOLX Position: Q2 2026 in Review

Ameriprise sold out of Hologic (HOLX) in Q2 2026, closing a stake of 618,084 shares — an estimated $46.7M sold.

Ameriprise first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $294M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Ameriprise reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 618,084 Hologic shares in Q2 2026, an estimated $46.7M.
  • Ameriprise first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • Ameriprise's Hologic position peaked at $294M in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.